Total raised
$44.1M
Last: Series D 2016-08
Stage
Series D
Founded
2003
Headcount
4
HQ
Bnei Brak
Sector
Health Tech & Life Sciences
About
Nutrinia is a neonatology company developing pharmaceuticals to treat rare conditions of the gastrointestinal tract. The company's current products in development are oral formulations of insulin shown to enhance adaptation and rehabilitation of the gut in infants. Nutrinia's insulin formulation is a powder that can be mixed with saline or infant formula before use. It is composed of insulin with excipients already approved for infant consumption, making it a safe drug product for infants. The formulation is intended to target and treat local GI issues with no absorption or systemic exposure.
Funding history · 4 rounds · $44.1M total
2016-08
Series D
$30.0M
2014-12
Series C
$12.0M
2008-11
Series B
$1.1M
2005-06
Series A
$1.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
oral-drugsgastroenterologypharmaceuticalsbabiesdoctorspatients